Huang T, Song X, Xu D, Tiek D, Goenka A, Wu B, et al. Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 2020;10:8721–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J, et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther. 2020;5:8.

Article  PubMed  PubMed Central  Google Scholar 

Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23:1124–34.

Article  CAS  PubMed  Google Scholar 

Gao M, Bai H, Jethava Y, Wu Y, Zhu Y, Yang Y, et al. Identification and characterization of tumor-initiating cells in multiple myeloma. J Natl Cancer Inst. 2020;112:507–15.

Article  PubMed  Google Scholar 

Lu S, Qian J, Guo M, Gu C, Yang Y. Insights into a crucial role of TRIP13 in human cancer. Comput Struct Biotechnol J. 2019;17:854–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vader G. Pch2TRIP13: controlling cell division through regulation of HORMA domains. Chromosoma. 2015;124:333–9.

Article  CAS  PubMed  Google Scholar 

Wang Y, Huang J, Li B, Xue H, Tricot G, Hu L, et al. A small-molecule inhibitor targeting TRIP13 suppresses multiple myeloma progression. Cancer Res. 2020;80:536–48.

Article  CAS  PubMed  Google Scholar 

Tao Y, Yang G, Yang H, Song D, Hu L, Xie B, et al. TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma. Oncotarget. 2017;8:26718–31.

Article  PubMed  PubMed Central  Google Scholar 

Li C, Xia J, Franqui-Machin R, Chen F, He Y, Ashby TC, et al. TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies. J Clin Investig. 2021;131:e146893.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamminga LM, Bystrykh LV, de Boer A, Houwer S, Douma J, Weersing E, et al. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood. 2006;107:2170–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su Ihsin, Hannon G, et al. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell. 2009;136:1122–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Avgustinova A, Benitah SA. Epigenetic control of adult stem cell function. Nat Rev Mol Cell Biol. 2016;17:643–58.

Article  CAS  PubMed  Google Scholar 

Shan Y, Liang Z, Xing Q, Zhang T, Wang B, Tian S, et al. PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs. Nat Commun. 2017;8:672.

Article  PubMed  PubMed Central  Google Scholar 

Pastushenko I, Mauri F, Song Y, de Cock F, Meeusen B, Swedlund B, et al. Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis. Nature. 2021;589:448–55.

Article  CAS  PubMed  Google Scholar